Another Trump appointee has been removed from a top communications post at FDA, continuing a shake-up of the agency’s media strategy after the troubled rollout of a coronavirus treatment authorization
The FDA’s communication strategy has been under significant scrutiny during the coronavirus pandemic — particularly after the agency last month gave emergency authorization for convalescent plasma to treat Covid-19 patients despite scant evidence of its effectiveness. Hahn and Miller toutedabout the treatment, prompting an apology from Hahn after severe blowback from the medical community.
Both Wagner and Miller will be replaced by civil servants, who have traditionally held communication roles at the science-focused agency. The White House, however, is considering appointing political replacements for those roles, said two people with knowledge of the administration’s personnel strategy.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA head open to authorizing a COVID-19 vaccine before end of phase 3.DrJohnTorres on FDA willing to fast track COVID-19 vaccine before phase 3 trials end: 'The concern is that they are kind of jumpstarting it a little bit ... that's what has a lot of experts concerned.'
Weiterlesen »
Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccines'The US_FDA announced that a public meeting of the Vaccines and Related Biological Products Advisory Committee will be held on Oct. 22, 2020, to discuss the general matter of the development, authorization, and/or licensure of [covid19 vaccines].'
Weiterlesen »
Doctors alarmed as FDA floats 'emergency use' of COVID-19 vaccine, bypassing trials“It’s a lesser review, it’s a lower-quality review, and when you’re talking about vaccinating a large chunk of the American population, that’s not acceptable,” said one vaccine expert.
Weiterlesen »
FDA says outside pressure won't influence COVID-19 vaccine approvalThe commissioner said, depending on that data, it&39;s possible a vaccine could be available by Election Day and before a Phase III trial is completely finished.
Weiterlesen »
FDA to bring outside experts to review COVID-19 vaccinesThe U.S. Food and Drug Administration will organize meetings with independent group of experts to review data of coronavirus vaccine candidates and advice the agency, FDA commissioner Stephen Hahn said on Wednesday.
Weiterlesen »
FDA: COVID Vaccine Could Be Given Before Tests EndEmergency use authorization or approval for a COVID-19 vaccine before Phase 3 clinical trials are complete could be considered by the U.S. Food and Drug Administratio
Weiterlesen »